MLLT3 and acute myeloid leukemia: Interestingly, MLLT3 also acts as a master regulator of human erythroid and megakaryocyte fate decision acting through GATA1 regulation51, possibly explaining the accumulation of erythroid-like AML clusters upon chemotherapy.